CXCR4 and pulmonary fibrosis: The EPs show deep lung penetration and cytosolic siRNA delivery to mediate highly effective pulmonary STAT3 silencing and CXCR4 inhibition in a mouse model of pulmonary fibrosis upon intratracheal administration.